| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/19/2006 | US7108850 Polypeptides of an IL-1-like cytokine |
| 09/19/2006 | CA2083493C Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 09/19/2006 | CA2083396C Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them |
| 09/14/2006 | WO2006096847A1 Obestatin and its uses |
| 09/14/2006 | WO2006096828A2 Chimeric proteins with phosphatidylserine binding domains |
| 09/14/2006 | WO2006096515A2 Modified transferrin fusion proteins |
| 09/14/2006 | WO2006096479A2 Protein separation from a protein mixture |
| 09/14/2006 | WO2006096473A2 Identification of polynucleotides for predicting activity of compunds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells |
| 09/14/2006 | WO2006096451A2 Methionine sulfoxide antibodies |
| 09/14/2006 | WO2006096441A2 Reagents, methods and systems to suppress phospholamban expression |
| 09/14/2006 | WO2006096345A2 Coagulation and fibrinolytic cascades modulator |
| 09/14/2006 | WO2006096073A1 High pressure processing of metal ion lactoferrin |
| 09/14/2006 | WO2006095775A1 Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue |
| 09/14/2006 | WO2006095347A2 VOLTAGE DEPENDENT ANION CHANNEL (VDACl) COMPOSITIONS AND METHODS OF USE THEREOF FOR REGULATING APOPTOSIS |
| 09/14/2006 | WO2006095167A1 Appetite-influencing medicaments |
| 09/14/2006 | WO2006095166A1 Modified pyy (3-36) peptides and their effects on feeding behaviour |
| 09/14/2006 | WO2006095164A1 Lipocalin protein |
| 09/14/2006 | WO2006095029A2 Di-polymer protein conjugates and processes for their preparation |
| 09/14/2006 | WO2006094973A1 Neuropeptides |
| 09/14/2006 | WO2006094813A2 Dimeric or multimeric microproteins |
| 09/14/2006 | WO2006094805A1 Photoproteins with enhanced bioluminescence and their use as intracellular calcium indicators |
| 09/14/2006 | WO2006094756A2 Varicella zoster virus vaccine |
| 09/14/2006 | WO2006094724A2 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies |
| 09/14/2006 | WO2006094530A1 Di-polymer protein conjugates and processes for their preparation |
| 09/14/2006 | WO2006094402A1 Novel hemoglobin scavenger receptor, cd163, and method of increasing cd163 expression on human stem cells and stimulation of erythroid progenitors |
| 09/14/2006 | WO2006080017A3 Biologically active silver-coated proteins |
| 09/14/2006 | WO2006078268A3 A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
| 09/14/2006 | WO2006075172A3 Methods for identifying compounds capable of modulating cftr/ck2 interaction and/or cftr phosphorylation by ck2 |
| 09/14/2006 | WO2006072787A8 Compositions for immunizing against mycobacterium |
| 09/14/2006 | WO2006072304A3 Tumor antigens for use in diagnosis and therapy |
| 09/14/2006 | WO2006070944A3 L-glutamic acid-producing microorganism and a method for producing l-glutamic acid |
| 09/14/2006 | WO2006068987A3 Uses of il-23 antagonists in the treatment of diabetes mellitus |
| 09/14/2006 | WO2006065582A3 Muteins of fibroblast growth factor 21 |
| 09/14/2006 | WO2006061242A3 Use of pta peptides for stratification of individuals having cancer |
| 09/14/2006 | WO2006056885A3 Igf-1 isoforms |
| 09/14/2006 | WO2006046017A3 Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter |
| 09/14/2006 | WO2006034334A3 Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response |
| 09/14/2006 | WO2006008484A3 Detection of cellular stress |
| 09/14/2006 | WO2006004748A3 Improved corn fractionation method |
| 09/14/2006 | WO2005122712A3 Soluble low-density lipoprotein receptor related protein binds directly to alzheimer’s amyloid-beta peptide |
| 09/14/2006 | WO2005121793A3 Detection of methamphetamine group drugs |
| 09/14/2006 | WO2005117964A3 Cynomolgus prostate specific antigen |
| 09/14/2006 | WO2005117936A3 Method for enhancing or inhibiting insulin-like growth factor-i |
| 09/14/2006 | WO2005115113A3 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 09/14/2006 | WO2005086667A3 High efficiency peptide production in plant cells |
| 09/14/2006 | WO2005053603A3 Antigen receptor variable region typing |
| 09/14/2006 | WO2005037392A3 Method for the dissociation of the extracellular haemoglobin molecule of arenicola marina and the characterisation of the protein chains forming the molecule and the nucleotide sequences coding for said protein chains |
| 09/14/2006 | WO2005021583A8 METHODS FOR IDENTIFYING, TREATING, AND INDUCING INFERTILITY USING SMC1β |
| 09/14/2006 | WO2005007121A3 Mutant interleukin-2(il-2) polypeptides |
| 09/14/2006 | WO2004108074A3 Vascular endothelial growth factor fusion constructs and uses thereof |
| 09/14/2006 | WO2004075836A3 STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS |
| 09/14/2006 | WO2004062619A3 SOLUBLE FcϜR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 09/14/2006 | WO2004037192A3 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases |
| 09/14/2006 | WO2003095614A3 Cytokine polypeptides |
| 09/14/2006 | WO2003089588A3 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof |
| 09/14/2006 | WO2003072759A3 Cloning and characterization of slc26a6, slc26a1, and slc26a2 anion exchangers |
| 09/14/2006 | US20060206967 Genetic control of flowering |
| 09/14/2006 | US20060206965 Combination of genes for the regulation of the induction of flowering in useful and ornamental plants |
| 09/14/2006 | US20060206962 Preparation of deallergenized proteins and permuteins |
| 09/14/2006 | US20060206959 Genetic engineering to modify genes in order to result in an ineffective target of the post-trascriptional gene silencing induced by geminiviruses; mutated polynucleotide sequence of a tomato infecting geminivirus |
| 09/14/2006 | US20060206958 Transforming a plant or plant cell with a nucleotide sequence operably linked to a promoter active in plant cells encoding an NRC1 protein and forming a transgenic plant; family Solanaceae, genus Solanum; cells, seeds, fruits |
| 09/14/2006 | US20060206951 GABA B1A receptor disruptions, compositions and methods relating thereto |
| 09/14/2006 | US20060206948 C-Reactive Protein (CRP); peptide biodrugs used to reduce body weight, adiposity, and alleviate insulin resistance and diabetes |
| 09/14/2006 | US20060205934 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 09/14/2006 | US20060205929 Protein extraction from canola oil seed meal |
| 09/14/2006 | US20060205928 Forming aqueous combination comprising blood and ion exchange resin at various pHs, agitating, and separating unbound materials |
| 09/14/2006 | US20060205927 Templated native silk smectic gels |
| 09/14/2006 | US20060205926 Human growth hormone domains |
| 09/14/2006 | US20060205925 Inhibits hemolysis by interacting with the plasma proteins clusterin; histidine rich glycoprotein (HRG); Streptococcal Inhibitor of Complement-mediated lysis |
| 09/14/2006 | US20060205924 Spliced variants of lgr6 |
| 09/14/2006 | US20060205923 For detecting the presence of FIV antibodies in a biological sample, bycontacting a biological sample from an animal with the FIV polypeptide |
| 09/14/2006 | US20060205689 BIVM (basic, immunoglobulin-like variable motif-containing) gene, transcriptional products, and uses thereof |
| 09/14/2006 | US20060205668 For therapy of spinal cord injury or stroke, by overcoming the inhibitory effects of myelin on axonal regeneration |
| 09/14/2006 | US20060205667 Wt1 substitution pepides |
| 09/14/2006 | US20060205666 Gamma-secretase inhibitors |
| 09/14/2006 | US20060205663 Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
| 09/14/2006 | US20060205660 OB protein-immunoglobulin chimeras |
| 09/14/2006 | US20060205659 Peptide radical having 5-25 amino acids with its N-terminus capped with a monoester of fumaric acid; used to treat autoimmune diseases, mitochondrial diseases, and NF-kappaB mediated diseases and in transplantation medicine |
| 09/14/2006 | US20060205656 P-superfamily conopeptides |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205654 Screening methods for identifying disorders related to huXAG-1, huXAG-2 or huXAG-3 (colon cancer specific gene) activity |
| 09/14/2006 | US20060205653 protein that potentiates toxin activity of a Class A toxin complex protein against an insect; insecticides |
| 09/14/2006 | US20060205643 Treatment of ischemia/reperfusion injury of the intestine, inflammatory bowel disease, acute infective colitis or pseudomembranous colitis by parenteral administration of high density lipoprotein |
| 09/14/2006 | US20060205641 VANILREP4 polypeptides and VANILREP4 polynucleotides |
| 09/14/2006 | US20060205640 Cationic peptide that inhibits the growth of both grampositive and/or gramnegative bacteria; isolated from the hemocytes of the sea squirt; can be used to treat antibiotic resistant tuberculosis, pneumonia, and urinary pathologies |
| 09/14/2006 | US20060205635 Antigene oligomers inhibit transcription |
| 09/14/2006 | US20060205091 Protein biopolymer markers predictive of insulin resistance |
| 09/14/2006 | US20060205069 Compositions comprising a first agent which provides a primary activation signal to T cells and a second agent which stimulates an accessory molecule on the surface of T cells |
| 09/14/2006 | US20060205068 Useful in identifying and designing novel Bt toxin receptor ligands including novel insecticidal toxins; manipulating Bt toxin susceptibility in plant pests |
| 09/14/2006 | US20060205046 Nucleotide sequences which code for the zwa1 gene |
| 09/14/2006 | US20060205043 Method for producing target substance by fermentation |
| 09/14/2006 | US20060205038 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 09/14/2006 | US20060205037 Modified transferrin fusion proteins |
| 09/14/2006 | US20060205036 Coagulation Factor VII polypeptides |
| 09/14/2006 | US20060205035 Expression vectors; transformed host cells; culturing the host cell to produce the encoded polypeptide; antiasthmatic agents |
| 09/14/2006 | US20060205034 Expression vector comprising nucleotide sequences coding membrane protein for identifying modulators for prevention and treatment of lung, gastrointestinal and cell proliferative disorders |
| 09/14/2006 | US20060205033 Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 09/14/2006 | US20060205032 hSLIM modulates immune responses |
| 09/14/2006 | US20060205021 Mammalian IAP gene family, primers, probes and detection methods |
| 09/14/2006 | US20060205020 Cell-cycle checkpoint genes |